These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2441107

  • 1. Bone histologic response to deferoxamine in aluminum-related bone disease.
    Andress DL, Nebeker HG, Ott SM, Endres DB, Alfrey AC, Slatopolsky EA, Coburn JW, Sherrard DJ.
    Kidney Int; 1987 Jun; 31(6):1344-50. PubMed ID: 2441107
    [Abstract] [Full Text] [Related]

  • 2. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
    Felsenfeld AJ, Rodriguez M, Coleman M, Ross D, Llach F.
    Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115
    [Abstract] [Full Text] [Related]

  • 3. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR, Evans RA, Hills E, Wong SY, Alfrey AC.
    Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL, Maloney NA, Endres DB, Sherrard DJ.
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [Abstract] [Full Text] [Related]

  • 6. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C, Armas JR, Palma A.
    Nefrologia; 2001 Oct; 21(2):174-81. PubMed ID: 11464651
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL, Maloney NA, Coburn JW, Endres DB, Sherrard DJ.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
    [Abstract] [Full Text] [Related]

  • 11. Osteomalacia and bone disease arising from aluminum.
    Coburn JW, Norris KC, Nebeker HG.
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Parathyroid glands in chronic aluminum intoxication.
    Cournot-Witmer G, Plachot JJ.
    Ultrastruct Pathol; 1990 Mar; 14(3):211-9. PubMed ID: 2356587
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Persisting aluminium-related bone disease after cadaveric renal transplantation.
    Nicholas JC, Dawes PT, Davies SJ, Freemont AJ.
    Nephrol Dial Transplant; 1999 Jan; 14(1):202-4. PubMed ID: 10052510
    [No Abstract] [Full Text] [Related]

  • 17. The effect of desferrioxamine on tissue aluminum concentration and bone histology in aluminum-loaded rats with renal failure.
    Verbeelen D, Smeyers-Verbeke J, van Hooff I, de Roy G.
    J Trace Elem Electrolytes Health Dis; 1988 Jun; 2(2):67-72. PubMed ID: 2980801
    [Abstract] [Full Text] [Related]

  • 18. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
    Parisien M, Charhon SA, Arlot M, Mainetti E, Chavassieux P, Chapuy MC, Meunier PJ.
    J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.
    Coburn JW, Norris KC.
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):12-21. PubMed ID: 3299588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.